Who is sponsoring NCT04160143?

NCT04160143 is sponsored by McMaster University.

What drugs are being tested in NCT04160143?

Interventions in NCT04160143: Surgical resection and stereotactic body radiation therapy (SBRT).

What condition does NCT04160143 study?

NCT04160143 studies Surgical Resection, Stereotactic Body Radiotherapy, Lung Cancer, Pulmonary Metastasectomy.

Is NCT04160143 still recruiting?

NCT04160143 is currently status unknown. Last updated 25 February 2021.

Last reviewed 2021-02-25 · How we verify

NCT04160143: PSPM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post SBRT Pulmonary Metastasectomy (PSPM) Trial

Status unknown NA Last updated 25 February 2021

What this trial tests

NA trial testing Surgical resection and stereotactic body radiation therapy (SBRT) in Surgical Resection in 39 participants. Status unknown.

Timeline

14 July 2020

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	McMaster University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	39
Start date	14 July 2020
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Canada

Drugs / interventions tested

Surgical resection and stereotactic body radiation therapy (SBRT)

Conditions studied

Surgical Resection — all drugs for Surgical Resection →
Stereotactic Body Radiotherapy — all drugs for Stereotactic Body Radiotherapy →
Lung Cancer — all drugs for Lung Cancer →
Pulmonary Metastasectomy — all drugs for Pulmonary Metastasectomy →

Sponsor

McMaster University

Who can join

18 and older, any sex, with Surgical Resection or Stereotactic Body Radiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to determine the effectiveness of SBRT on reducing tumor viability at a pathologic level and also to evaluate the effects of combined modality treatment on low volume pulmonary metastases, in hopes of extrapolating this information to both primary and secondary lung cancer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Redefining cancer care: harnessing circulating tumor cells' potential for improved diagnosis and prognosis.
Janjua D, Chaudhary A, Joshi U, Tripathi T, et al · · 2025 · cited 4× · PMID 40676582 · DOI 10.1186/s12935-025-03883-y
The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy-rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial.
Begum H, Swaminath A, Lee Y, Fahim C, et al · · 2022 · cited 4× · PMID 35571641 · DOI 10.21037/tcr-22-232

Verify or expand the search:

Other recruiting trials for Surgical Resection

Currently open trials in the same condition.

NCT06709833 — Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation · recruiting

Other McMaster University trials

Trials by the same sponsor.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04160143 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McMaster University
Last refreshed: 25 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing